Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 23
2005 34
2006 36
2007 47
2008 47
2009 53
2010 46
2011 62
2012 65
2013 59
2014 49
2015 40
2016 44
2017 57
2018 58
2019 45
2020 51
2021 55
Text availability
Article attribute
Article type
Publication date

Search Results

780 results
Results by year
Filters applied: . Clear all
Page 1
Drug safety evaluation of aripiprazole in bipolar disorder.
Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A. Cuomo A, et al. Expert Opin Drug Saf. 2019 Jun;18(6):455-463. doi: 10.1080/14740338.2019.1617847. Epub 2019 May 17. Expert Opin Drug Saf. 2019. PMID: 31072228 Review.
Introduction: Safety and tolerability of medications are key variables to inform treatment choice for patients with bipolar disorder (BD). This review focuses on the overall tolerability and safety profile of aripiprazole when used for its bipolar disorder in …
Introduction: Safety and tolerability of medications are key variables to inform treatment choice for patients with bipolar disorder …
Aripiprazole.
Gettu N, Saadabadi A. Gettu N, et al. 2021 Sep 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. 2021 Sep 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 31613519 Free Books & Documents. Review.
Aripiprazole is a medication used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability associated with an autism spectrum disorder, disjunctive therapy in major depressive disorder, and Tourette syndrome. ...This activity reviews
Aripiprazole is a medication used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability as
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH. Calabrese JR, et al. J Clin Psychiatry. 2017 Mar;78(3):324-331. doi: 10.4088/JCP.16m11201. J Clin Psychiatry. 2017. PMID: 28146613 Free article. Clinical Trial.
OBJECTIVE: To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) as maintenance treatment for bipolar I disorder (BP-I). METHODS: In a double-blind, placebo-controlled, 52-week randomized wi …
OBJECTIVE: To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (A …
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.
Li DJ, Tseng PT, Stubbs B, Chu CS, Chang HY, Vieta E, Fornaro M, Carvalho AF, Solmi M, Veronese N, Chen TY, Chen YW, Lin PY, Chow PC. Li DJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):289-301. doi: 10.1016/j.pnpbp.2017.06.023. Epub 2017 Jun 23. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 28651936 Review.
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. ...Aripiprazole was associa …
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehe …
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.
Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E. Pacchiarotti I, et al. Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470. doi: 10.1016/j.euroneuro.2019.02.003. Epub 2019 Feb 12. Eur Neuropsychopharmacol. 2019. PMID: 30770235 Free article. Review.
We aimed to summarize available evidence of studies comparing the efficacy of LAIs to placebo or oral medications for Bipolar Disorder (BD) and/or Schizoaffective Disorder (SAD). We searched six databases from inception to 28-March-2018, using the strategy: long-acting ant …
We aimed to summarize available evidence of studies comparing the efficacy of LAIs to placebo or oral medications for Bipolar Disorde …
Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Bahji A, et al. J Affect Disord. 2020 May 15;269:154-184. doi: 10.1016/j.jad.2020.03.030. Epub 2020 Mar 20. J Affect Disord. 2020. PMID: 32339131 Review.
Escitalopram, phenelzine, moclobemide, carbamazepine, sertraline, lithium, paroxetine, aripiprazole, gabapentin and ziprasidone appear to be ineffective as compared to placebo in treatment of bipolar depression. Divalproex, olanzapine/fluoxetine, olanzapine, quetiap …
Escitalopram, phenelzine, moclobemide, carbamazepine, sertraline, lithium, paroxetine, aripiprazole, gabapentin and ziprasidone appea …
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice.
Cuomo A, Goracci A, Fagiolini A. Cuomo A, et al. J Affect Disord. 2018 Mar 1;228:229-237. doi: 10.1016/j.jad.2017.12.021. Epub 2017 Dec 14. J Affect Disord. 2018. PMID: 29275156 Review.
BACKGROUND: Aripiprazole is used relatively frequently in women with bipolar disorder or schizophrenia in childbearing years, owing to its efficacy and relatively favorable side effect profile. ...In many cases, the potential benefits of aripiprazole for pati …
BACKGROUND: Aripiprazole is used relatively frequently in women with bipolar disorder or schizophrenia in childbearing years, …
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
Rapinesi C, Kotzalidis GD, Mazzarini L, Brugnoli R, Ferracuti S, De Filippis S, Cuomo I, Giordano G, Del Casale A, Angeletti G, Sani G, Girardi P. Rapinesi C, et al. Clin Drug Investig. 2019 Aug;39(8):713-735. doi: 10.1007/s40261-019-00801-9. Clin Drug Investig. 2019. PMID: 31152368
OBJECTIVE: To systematically review the effects of the two formulations, Monohydrate and Lauroxil, of Aripiprazole LAI in patients with schizophrenia and bipolar disorder during an acute episode or during maintenance treatment. ...RESULTS: We included 28 papers deal …
OBJECTIVE: To systematically review the effects of the two formulations, Monohydrate and Lauroxil, of Aripiprazole LAI in patients wi …
Aripiprazole.
[No authors listed] [No authors listed] 2017 Jul 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jul 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643195 Free Books & Documents. Review.
Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and bipolar illness. Aripiprazole therapy has not been associated consistently with serum aminotransferase elevations and has yet to be linked to cases of clinically apparent acu
Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and bipolar illness. Aripiprazole ther
Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults.
Aggarwal A, Schrimpf L, Lauriello J. Aggarwal A, et al. Clin Schizophr Relat Psychoses. 2018 Jan;11(4):221-223. doi: 10.3371/CSRP.AGSC.010318. Clin Schizophr Relat Psychoses. 2018. PMID: 29341822 Review.
Bipolar I disorder is a serious and disabling psychiatric illness. ...In this paper we discuss the available data for safety and efficacy of aripiprazole long-acting injectable in bipolar disorder....
Bipolar I disorder is a serious and disabling psychiatric illness. ...In this paper we discuss the available data for safety and effi
780 results